![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University Hospital, Angers |
---|---|
Information provided by: | University Hospital, Angers |
ClinicalTrials.gov Identifier: | NCT00152711 |
This study aims to evaluate the impact of nasal continuous positive airway pressure (nCPAP) treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic steatohepatitis. Using a cross over design, the evolution of liver enzymes will be evaluated in 40 patients during a consecutive period of 6 weeks, with and without nCPAP treatment.
Condition | Intervention |
---|---|
Sleep Apnea Syndrome Nonalcoholic Steatohepatitis |
Device: nCPAP |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment |
Official Title: | Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: A Prospective Cross Over Trial |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Frédéric Gagnadoux, MD | 33(0)241353695 | frgagnadoux@chu-angers.fr |
France | |
University Hospital Angers | Recruiting |
Angers, France | |
Contact: Frédéric Gagnadoux, MD 33(0)241353695 frgagnadoux@chu-angers.fr |
Principal Investigator: | Frédéric Gagnadoux | UH Angers |
Study ID Numbers: | PHRC 03-07 |
Study First Received: | September 8, 2005 |
Last Updated: | February 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00152711 |
Health Authority: | France: French General Health Administration |
Signs and Symptoms Liver Diseases Sleep Apnea Syndromes Digestive System Diseases Respiratory Tract Diseases Apnea |
Respiration Disorders Dyssomnias Sleep Disorders Signs and Symptoms, Respiratory Fatty Liver Sleep Disorders, Intrinsic |
Pathologic Processes Disease Syndrome Nervous System Diseases |